Loading clinical trials...

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00922272

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

To explore the efficacy of SPD489, as adjunctive therapy to a stable dose of atypical antipsychotic medication, on negative symptoms in adult subjects with clinically stable schizophrenia and predomin...

Lead sponsor: Shire•27 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

NCT07428460 · Schizophrenia and Predominant Negative Symptoms

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment92

Start dateSep 2009

Last updatedJun 9, 2021

Condition

Schizophrenia and Predominant Negative Symptoms

Locations shown

K&S Professional Research Services

Little Rock, Arkansas

South Coast Clinical Trials

Anaheim, California

Omega Clinical Trials

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions